Funded Startups in Novato
Across Novato’s 12 most recent funded entries, the largest disclosed round is QT Imaging’s $10M on 2026-05-15, and it sits well above most other disclosed…
Across Novato’s 12 most recent funded entries, the largest disclosed round is QT Imaging’s $10M on 2026-05-15, and it sits well above most other disclosed amounts (e.g., Lighthouse Pharma’s $12M on 2026-04-23 is actually the top disclosed figure, so QT Imaging’s $10M is near the upper tier rather than the peak). The size distribution is skewed by mid-size checks: only two disclosed rounds exceed $2M ($12M Lighthouse Pharma on 2026-04-23; $10M QT Imaging on 2026-05-15; with Agent Craft at $350K on 2026-05-19 and Maker Wine at $2M on 2021-11-18 anchoring the lower end). On timing, the list clusters tightly in 2026: four of the 12 rounds are dated between 2026-04-23 and 2026-05-19, while the oldest row shown dates back to 2021-11-18 (Maker Wine). Sector-wise, AI appears in multiple rows (Agent Craft; Sutter Instrument; Sandy Health; Lighthouse Pharma), and healthcare is also repeated (Lighthouse Pharma; Sandy Health; QT Imaging; Sutter Instrument), suggesting recurring funding interest rather than a single one-off theme. Disclosed amounts are missing for several entries: 2 rows are marked “undisclosed” and 1 row is “Series Unknown,” adding uncertainty around stage and deal size.
Most recent rounds
12 shownRelated listings
Frequently asked
What’s the largest disclosed funding amount in the Novato set, and is it a clear outlier versus other disclosed rounds?
The largest disclosed round is Lighthouse Pharma’s $12M on 2026-04-23. That figure is well above the next-largest disclosed rounds in the table—QT Imaging’s $10M on 2026-05-15—and both stand out against the rest of the disclosed amounts like $2M (Sandy Health on 2025-11-06) and $360K (Dickinson Corporation on 2024-06-03).
How concentrated are these rounds in time, based on the most recent dates shown?
Four of the 12 entries land in a narrow window in 2026, from 2026-04-23 (Lighthouse Pharma) through 2026-05-19 (Agent Craft). After that, the list stretches back to 2021-11-18 (Maker Wine), indicating the recency cluster is centered heavily in spring 2026 rather than evenly distributed.
Which sectors appear repeatedly enough to suggest a pattern rather than isolated deals?
Artificial Intelligence shows up in at least four companies: Agent Craft (Seed, 2026-05-19; $350K), Sutter Instrument (Series Unknown, 2026-05-12; undisclosed), Sandy Health (Pre-Seed, 2025-11-06; $2M), and Lighthouse Pharma (Series A, 2026-04-23; $12M). Healthcare is also recurring across entries like QT Imaging (2026-05-15; $10M), Lighthouse Pharma (2026-04-23; $12M), and Sandy Health (2025-11-06; $2M).
What does the stage mix look like among recently dated rounds, and where is the uncertainty?
Recent entries include Seed (Agent Craft on 2026-05-19; $350K), Series A (Lighthouse Pharma on 2026-04-23; $12M), and “Series Unknown” appears on multiple rows such as QT Imaging (2026-05-15; $10M) and Sutter Instrument (2026-05-12; undisclosed). The table also contains non-standard stage labels like Pre-Seed for Sandy Health (2025-11-06; $2M), so stage information is partially granular and partially unknown.
Are there notable data gaps or small-deal outliers that affect how confidently deal-size comparisons can be made?
Two rows have “undisclosed” amounts (Sutter Instrument on 2026-05-12; IPSecure on 2024-02-14), which limits full comparisons by disclosed size. On the low end among disclosed amounts, NBCC’s $20K on 2024-02-13 is far smaller than mid-tier checks like Dickinson Corporation’s $360K on 2024-06-03 and Agent Craft’s $350K on 2026-05-19.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.